Tus kws kho mob
P71-19 Attachments for Minnesota Health Care Programs (MHCP) Claims
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2961 - 2970 ntawm 4138
Tus kws kho mob
QP101-18 Pharmacy Update for Praluent (alirocumab) and Repatha (evolocumab)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2018
Tus kws kho mob
2018 December Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 03, 2018
Tus kws kho mob
QP97-18 Withdraw Feature Available for Availity Authorizations
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP92-18 Addition of Drug to the Topical Lidocaine Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP59-18 eviCore Prior Authorization Reminder
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 26, 2018
Tus kws kho mob
QP96-18 Clarification Regarding the use of PLUTO for Minnesota Health Care Program Subscribers Effective December 1, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP81-18 Changes to Cotiviti Mailroom Operations Center Location
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 25, 2018
Tus kws kho mob
QP78-18 Pharmacy Update - Change in Coverage for Brand Serevent Diskus 50 mcg/dose
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP71-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018